Evolutionary Genomics, Inc. Stock
Stocks
FNAM
US30051F1012
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000200 USD | -.--% |
|
-.--% | - |
| 23-03-09 | Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 23-03-08 | Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 2.99M 2.62M 2.42M 2.24M 4.21M 288M 4.29M 28.85M 11.32M 141M 11.25M 11M 485M | P/E 2021 |
-1.34x | P/E 2022 | -2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.16M 5.38M 4.98M 4.6M 8.66M 592M 8.82M 59.36M 23.29M 290M 23.14M 22.63M 998M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
67.35% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0.45 | |
| 5 years | 0 | 1.05 | |
| 10 years | 0 | 5.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Walter Messier
CTO | Chief Tech/Sci/R&D Officer | 71 | 1999-12-31 |
Steve Warnecke
CEO | Chief Executive Officer | 70 | 2014-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Steve Warnecke
CHM | Chairman | 70 | 2014-09-30 |
| Director/Board Member | 76 | 1999-12-31 | |
Mark Boggess
BRD | Director/Board Member | 66 | 2009-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22-05-22 | Fiscal year | Founder | 55,714 | 0.8422% | ||
| 22-05-22 | Fiscal year | Chief Executive Officer | 185,715 | 2.8074% | ||
| 22-05-22 | Fiscal year | Founder | 278,571 | 4.2111% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -.--% | -99.97% | 1.33K | ||
| -0.33% | +1.22% | +2.91% | +7.17% | 50.35B | ||
| +0.55% | -2.88% | +382.07% | +593.81% | 39.32B | ||
| +0.13% | -0.19% | +29.79% | -6.00% | 34.69B | ||
| +0.86% | -0.78% | +21.58% | +56.15% | 34.08B | ||
| -1.31% | -3.03% | +2.51% | +25.24% | 26.63B | ||
| +0.13% | -0.52% | - | - | 16.49B | ||
| +1.13% | -1.85% | +67.36% | +120.46% | 15.31B | ||
| +0.23% | +3.13% | +14.73% | +17.74% | 13.8B | ||
| +1.13% | -0.44% | +12.34% | -31.79% | 12.87B | ||
| Average | +0.25% | -0.74% | +59.25% | +75.87% | 24.35B | |
| Weighted average by Cap. | +0.17% | -0.73% | +81.04% | +122.31% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.79M -2.44M -2.26M -2.09M -3.93M -268M -4M -26.92M -10.56M -131M -10.49M -10.26M -452M | -1.93M -1.69M -1.56M -1.44M -2.72M -186M -2.77M -18.64M -7.31M -91.01M -7.27M -7.11M -313M |
| Net Debt | 3.53M 3.08M 2.85M 2.63M 4.96M 339M 5.05M 34.01M 13.34M 166M 13.26M 12.97M 572M | 3.17M 2.77M 2.56M 2.36M 4.45M 304M 4.53M 30.51M 11.97M 149M 11.89M 11.63M 513M |
Employees
3
- Stock Market
- Stocks
- FNAM Stock
Select your edition
All financial news and data tailored to specific country editions
















